Literature DB >> 2235878

The molecular weight dependence of nasal absorption: the effect of absorption enhancers.

M D Donovan1, G L Flynn, G L Amidon.   

Abstract

A series of polyethylene glycols (PEGs) ranging in molecular weight from near 600 to over 2000 daltons was used to study the effects of three absorption enhancers (sodium glycocholate, sodium lauryl sulfate, and polyoxyethylene 9 lauryl ether) on the molecular weight permeability profile of the nasal mucosa of the rat. Molecular weight-permeability properties were studied both by following changes in the excretion of the polyethylene glycols as a function of their molecular size and by examining the nasal mucosa for morphologic changes following exposure to the PEG/enhancer mixtures. Each absorption enhancer was found to affect the mucosa and its permeability in a unique manner. At a 1% concentration, sodium glycocholate only slightly affects tissue morphology and does not significantly alter the molecular weight permeability profile of the mucosa. In contrast, 1% sodium lauryl sulfate causes severe alteration of the mucosa and also greatly increases the absorption of both the PEG 600 and the PEG 2000 oligomers. Polyoxyethylene 9 lauryl ether was found to exert its action in a concentration-dependent manner. At a concentration of 0.1%, few changes were seen in either mucosal integrity or permeability. At a 1% concentration, however, a significant alteration in the structure of the mucosal tissues as well as a profound increase in the permeability of the mucosa to the PEGs was observed. Correlation of mucosal integrity with the effectiveness of an enhancer indicates that some of these compounds appear to be acting by altering the structure of the mucosa.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2235878     DOI: 10.1023/a:1015904730599

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  21 in total

1.  Nasal absorption of insulin in dogs.

Authors:  S Harai; T Ikenaga; T Matsuzawa
Journal:  Diabetes       Date:  1978-03       Impact factor: 9.461

2.  Site dependence of absorption-promoting actions of laureth-9, Na salicylate, Na2EDTA, and aprotinin on rectal, nasal, and buccal insulin delivery.

Authors:  B J Aungst; N J Rogers
Journal:  Pharm Res       Date:  1988-05       Impact factor: 4.200

3.  Differential solubilization of proteins, phospholipids, and cholesterol of erythrocyte membranes by detergents.

Authors:  F H Kirkpatrick; S E Gordesky; G V Marinetti
Journal:  Biochim Biophys Acta       Date:  1974-04-29

4.  Metabolic effects of intranasally administered glucagon: comparison with intramuscular and intravenous injection.

Authors:  A E Pontiroli; M Alberetto; G Pozza
Journal:  Acta Diabetol Lat       Date:  1985 Apr-Jun

5.  Absorption from the nasal mucous membrane. I. Nasal absorption of hydralazine in rats.

Authors:  Y Kaneo
Journal:  Acta Pharm Suec       Date:  1983

6.  Intranasal glucagon raises blood glucose concentrations in healthy volunteers.

Authors:  A E Pontiroli; M Alberetto; G Pozza
Journal:  Br Med J (Clin Res Ed)       Date:  1983-08-13

7.  Studies on the promoting effects of medium chain fatty acid salts on the nasal absorption of insulin in rats.

Authors:  M Mishima; Y Wakita; M Nakano
Journal:  J Pharmacobiodyn       Date:  1987-11

8.  Polyethylene glycol 900 permeability of rat intestinal and colonic segments in vivo and brush border membrane vesicles in vitro.

Authors:  D Hollander; S Koyama; V Dadufalza; D Q Tran; P Krugliak; T Ma; K Y Ling
Journal:  J Lab Clin Med       Date:  1989-04

9.  Intranasal aerosolized insulin. Mixed-meal studies and long-term use in type I diabetes.

Authors:  R Salzman; J E Manson; G T Griffing; R Kimmerle; N Ruderman; A McCall; E I Stoltz; C Mullin; D Small; J Armstrong
Journal:  N Engl J Med       Date:  1985-04-25       Impact factor: 91.245

10.  Insulin given intranasally induces hypoglycaemia in normal and diabetic subjects.

Authors:  A E Pontiroli; M Alberetto; A Secchi; G Dossi; I Bosi; G Pozza
Journal:  Br Med J (Clin Res Ed)       Date:  1982-01-30
View more
  11 in total

Review 1.  Absorption enhancers for nasal drug delivery.

Authors:  Stanley S Davis; Lisbeth Illum
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  Evidence for LHRH-receptor expression in human airway epithelial (Calu-3) cells and its role in the transport of an LHRH agonist.

Authors:  Kavitha Koushik; Nagesh Bandi; Sneha Sundaram; Uday B Kompella
Journal:  Pharm Res       Date:  2004-06       Impact factor: 4.200

3.  Effects of absorption enhancers on rat nasal epithelium in vivo: release of marker compounds in the nasal cavity.

Authors:  E Marttin; J C Verhoef; S G Romeijn; F W Merkus
Journal:  Pharm Res       Date:  1995-08       Impact factor: 4.200

4.  The physicochemical properties, plasma enzymatic hydrolysis, and nasal absorption of acyclovir and its 2'-ester prodrugs.

Authors:  Z Shao; G B Park; R Krishnamoorthy; A K Mitra
Journal:  Pharm Res       Date:  1994-02       Impact factor: 4.200

5.  Bile salt-fatty acid mixed micelles as nasal absorption promoters. III. Effects on nasal transport and enzymatic degradation of acyclovir prodrugs.

Authors:  Z Shao; A K Mitra
Journal:  Pharm Res       Date:  1994-02       Impact factor: 4.200

Review 6.  Pharmacology of bile acids and their derivatives: absorption promoters and therapeutic agents.

Authors:  M Mikov; J P Fawcett; K Kuhajda; S Kevresan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2006 Jul-Sep       Impact factor: 2.441

7.  Absorption of recombinant human granulocyte colony-stimulating factor (rhG-CSF) from rat nasal mucosa.

Authors:  M Machida; K Sano; M Arakawa; M Hayashi; S Awazu
Journal:  Pharm Res       Date:  1993-09       Impact factor: 4.200

8.  Cyclodextrins as nasal absorption promoters of insulin: mechanistic evaluations.

Authors:  Z Shao; R Krishnamoorthy; A K Mitra
Journal:  Pharm Res       Date:  1992-09       Impact factor: 4.200

9.  Dissociation of insulin oligomers by bile salt micelles and its effect on alpha-chymotrypsin-mediated proteolytic degradation.

Authors:  Y Li; Z Shao; A K Mitra
Journal:  Pharm Res       Date:  1992-07       Impact factor: 4.200

10.  In vitro tolerability of human nasal mucosa: histopathological and scanning electron-microscopic evaluation of nasal forms containing Sandostatin.

Authors:  A de Fraissinette; M Kolopp; I Schiller; G Fricker; C Gammert; A Pospischil; J Vonderscher; F Richter
Journal:  Cell Biol Toxicol       Date:  1995-10       Impact factor: 6.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.